NO306614B1 - Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler - Google Patents

Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler

Info

Publication number
NO306614B1
NO306614B1 NO945034A NO945034A NO306614B1 NO 306614 B1 NO306614 B1 NO 306614B1 NO 945034 A NO945034 A NO 945034A NO 945034 A NO945034 A NO 945034A NO 306614 B1 NO306614 B1 NO 306614B1
Authority
NO
Norway
Prior art keywords
derivatives
vitamin
pharmaceuticals
manufacture
preparation
Prior art date
Application number
NO945034A
Other languages
English (en)
Norwegian (no)
Other versions
NO945034L (no
NO945034D0 (no
Inventor
Andreas Steinmeyer
Guenter Neef
Gerald Kirsch
Katica Schwarz
Ruth Thieroff-Ekerdt
Herbert Wiesinger
Martin Haberey
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO945034D0 publication Critical patent/NO945034D0/no
Publication of NO945034L publication Critical patent/NO945034L/no
Publication of NO306614B1 publication Critical patent/NO306614B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/517Saturated compounds containing a keto group being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO945034A 1992-06-24 1994-12-23 Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler NO306614B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4220757A DE4220757A1 (de) 1992-06-24 1992-06-24 Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
PCT/EP1993/001620 WO1994000428A1 (de) 1992-06-24 1993-06-24 Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln

Publications (3)

Publication Number Publication Date
NO945034D0 NO945034D0 (no) 1994-12-23
NO945034L NO945034L (no) 1995-02-24
NO306614B1 true NO306614B1 (no) 1999-11-29

Family

ID=6461752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO945034A NO306614B1 (no) 1992-06-24 1994-12-23 Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler

Country Status (24)

Country Link
US (2) US5585368A (zh)
EP (1) EP0647219B1 (zh)
JP (1) JPH08501531A (zh)
KR (1) KR100300274B1 (zh)
CN (2) CN1055921C (zh)
AT (1) ATE140918T1 (zh)
AU (1) AU679685B2 (zh)
CA (1) CA2138989A1 (zh)
CZ (1) CZ282151B6 (zh)
DE (2) DE4220757A1 (zh)
DK (1) DK0647219T3 (zh)
ES (1) ES2093440T3 (zh)
FI (1) FI111720B (zh)
GR (1) GR3020974T3 (zh)
HU (1) HUT70563A (zh)
IL (1) IL106128A0 (zh)
MX (1) MX9303799A (zh)
NO (1) NO306614B1 (zh)
NZ (1) NZ253698A (zh)
PL (1) PL174024B1 (zh)
SK (1) SK281244B6 (zh)
TW (1) TW255883B (zh)
WO (1) WO1994000428A1 (zh)
ZA (1) ZA934550B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
KR100244060B1 (ko) * 1994-04-11 2000-02-01 나가야마 오사무 22-티아비타민 디3 유도체
DE69508895T2 (de) * 1994-12-14 1999-10-21 Duphar Int Res Vitamin-D-Derivate und Verfahren zur Herstellung dieser Verbindungen
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
CA2175881A1 (en) * 1995-05-09 1996-11-10 Andrzej Kutner Vitamin d compounds and methods of preparing these compounds
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US6028208A (en) * 1997-06-25 2000-02-22 Teijin Limited Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
WO1999012894A1 (en) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
DE19744127B4 (de) * 1997-10-01 2006-10-05 Schering Ag Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US20030220307A1 (en) * 2000-08-17 2003-11-27 Akira Kawase Remedial agent for osteoporosis
US7491711B2 (en) * 2001-09-21 2009-02-17 Roche Palo Alto Llc Methods of treatment using 3-desoxy vitamin D3 analogs
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20090298800A1 (en) * 2005-09-23 2009-12-03 Bioxell S.P.A. 1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof
MX2009000660A (es) 2006-07-17 2009-04-08 Glaxosmithkline Biolog Sa Vacuna de influenza.
US7888339B2 (en) 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
JP5932339B2 (ja) 2009-01-27 2016-06-08 バーグ エルエルシー 化学療法に付随する副作用を軽減するためのビタミンd3およびその類似体
IN2012DN02137A (zh) 2009-08-14 2015-08-07 Berg Biosystems Llc
CN103073607B (zh) * 2013-02-26 2014-09-03 昆明理工大学 12β-羟基雄甾-4,6,8(9),13(14)-四烯-3,11,16-三酮及其应用
CN103073608B (zh) * 2013-02-26 2014-09-03 昆明理工大学 雄甾-4,6,8(9),13(14)-四烯-3,11,16-三酮及其应用
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd 1α.25−ジヒドロキシ−26.27−ジメチルビタミンD↓3
DE3577552D1 (de) * 1984-11-27 1990-06-13 Chugai Pharmaceutical Co Ltd Vitamin d-derivate und verfahren zu deren herstellung.
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
ATE45347T1 (de) * 1985-05-30 1989-08-15 Taisho Pharmaceutical Co Ltd Vitamin d3-derivate.
US4832875A (en) * 1985-11-21 1989-05-23 Taisho Pharmaceutical Co., Ltd. Vitamin D3 derivative
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US4970203A (en) * 1988-12-09 1990-11-13 Deluca Hector F Method for improving reproductive functions in mammals
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
ES2093180T3 (es) * 1991-07-05 1996-12-16 Duphar Int Res Compuesto de vitamina d, metodo de preparar este compuesto y producto intermedio de dicho metodo.
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
PL174024B1 (pl) 1998-06-30
FI946073A (fi) 1994-12-23
NZ253698A (en) 1996-11-26
CA2138989A1 (en) 1994-01-06
GR3020974T3 (en) 1996-12-31
CZ327694A3 (en) 1995-06-14
TW255883B (zh) 1995-09-01
US5585368A (en) 1996-12-17
EP0647219B1 (de) 1996-07-31
CZ282151B6 (cs) 1997-05-14
NO945034L (no) 1995-02-24
US5700791A (en) 1997-12-23
IL106128A0 (en) 1993-10-20
DK0647219T3 (da) 1996-12-09
MX9303799A (es) 1994-07-29
AU4500793A (en) 1994-01-24
WO1994000428A1 (de) 1994-01-06
CN1089599A (zh) 1994-07-20
DE59303365D1 (de) 1996-09-05
FI111720B (fi) 2003-09-15
CN1055921C (zh) 2000-08-30
SK158494A3 (en) 1995-07-11
EP0647219A1 (de) 1995-04-12
FI946073A0 (fi) 1994-12-23
CN1173909C (zh) 2004-11-03
HU9403771D0 (en) 1995-02-28
ZA934550B (en) 1994-01-27
ES2093440T3 (es) 1996-12-16
NO945034D0 (no) 1994-12-23
JPH08501531A (ja) 1996-02-20
ATE140918T1 (de) 1996-08-15
SK281244B6 (sk) 2001-01-18
AU679685B2 (en) 1997-07-10
KR100300274B1 (ko) 2001-11-22
DE4220757A1 (de) 1994-01-05
CN1262267A (zh) 2000-08-09
HUT70563A (en) 1995-10-30
KR950702181A (ko) 1995-06-19

Similar Documents

Publication Publication Date Title
NO306614B1 (no) Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler
MX9707453A (es) Derivados de quinazolina.
HUT64314A (en) Process for production isoxazole-4-carboxylic acid amides and hydroxi-alkylidene-cyanic-acetic acid amides and pharmaceutical preparations having these compounds
FI942076A (fi) Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina
HUP9602685A2 (hu) Helyettesített kinolin-2-karbonsav-amidok, eljárás előállításukra és alkalmazásuk gyógyszerekként, valamint közbenső termékek
MX9604020A (es) Arilalquildiazinonas.
DE69715439T2 (de) Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel
HUP9802121A2 (hu) Imidazolinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyszerkészítmények
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ATE4642T1 (de) 2-hydroxyalkyl-3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK383388A (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE60041137D1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE3768529D1 (de) Isohexid-nukleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ATE170527T1 (de) Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel
YU38497A (sh) Derivati 1-karba-(detia)-cefalosporina, njihova proizvodnja, intermedijeri koji se koriste u toj proizvodnji, odgovarajući farmaceutski preparati i upotreba jedinjenja za proizvodnju farmaceutskih preparata
HUP0103992A2 (hu) Pregnán-glükuronidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69916103D1 (de) 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie